CHEBI:47657 - roflumilast

ChEBI IDCHEBI:47657
ChEBI Nameroflumilast
Stars
DefinitionA benzamide obtained by formal condensation of the carboxy group of 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid with the amino group of 3,5-dichloropyridin-4-amine. Used for treatment of bronchial asthma and chronic obstructive pulmonary disease.
Last Modified22 February 2017
DownloadsMolfile
FormulaC17H14Cl2F2N2O3
Net Charge0
Average Mass403.212
Monoisotopic Mass402.03495
SMILESO=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
InChIInChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)
InChIKeyMNDBXUUTURYVHR-UHFFFAOYSA-N
Wikipedia
Roles Classification
Biological Roles:
phosphodiesterase IV inhibitor  An EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor that specifically blocks the action of phosphodiesterase IV.
anti-obesity agent  Any substance which is used to reduce or control weight.
Applications:
anti-asthmatic agent  Any compound that has anti-asthmatic effects.
dermatologic drug  A drug used to treat or prevent skin disorders or for the routine care of skin.
hypoglycemic agent  A drug which lowers the blood glucose level.
antipsoriatic  A drug used to treat psoriasis.
anti-asthmatic drug  A drug used to treat asthma.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
antidepressant  Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
antipsychotic agent  Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
ChEBI Ontology
Outgoing Relation(s)
roflumilast (CHEBI:47657) has role anti-asthmatic agent (CHEBI:65023)
roflumilast (CHEBI:47657) has role anti-asthmatic drug (CHEBI:49167)
roflumilast (CHEBI:47657) has role anti-obesity agent (CHEBI:74518)
roflumilast (CHEBI:47657) has role antidepressant (CHEBI:35469)
roflumilast (CHEBI:47657) has role antineoplastic agent (CHEBI:35610)
roflumilast (CHEBI:47657) has role antipsoriatic (CHEBI:50748)
roflumilast (CHEBI:47657) has role antipsychotic agent (CHEBI:35476)
roflumilast (CHEBI:47657) has role dermatologic drug (CHEBI:50177)
roflumilast (CHEBI:47657) has role hypoglycemic agent (CHEBI:35526)
roflumilast (CHEBI:47657) has role phosphodiesterase IV inhibitor (CHEBI:68844)
roflumilast (CHEBI:47657) is a aromatic ether (CHEBI:35618)
roflumilast (CHEBI:47657) is a benzamides (CHEBI:22702)
roflumilast (CHEBI:47657) is a chloropyridine (CHEBI:39173)
roflumilast (CHEBI:47657) is a cyclopropanes (CHEBI:51454)
roflumilast (CHEBI:47657) is a organofluorine compound (CHEBI:37143)
IUPAC Name 
3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
INNs  Source
roflumilastWHO MedNet
roflumilastWHO MedNet
roflumilastKEGG DRUG
roflumilastumWHO MedNet
Synonyms  Source
Arq-151ChEMBL
ARQ-154 (ROFLUMILAST FOAM)ChEMBL
B-9302-107ChEMBL
BY-217ChEMBL
BYK-20869ChEMBL
ZoryveChEMBL
Brand Name  Source
DalirespKEGG DRUG
Manual XrefsDatabases
3531DrugCentral
D05744KEGG DRUG
ROFPDBeChem
RoflumilastWikipedia
US2008181876Patent
US2008221111Patent
WO2008017827Patent
WO2008090355Patent
Registry NumbersSources
Reaxys:9802592Reaxys
CAS:162401-32-3KEGG DRUG
CAS:162401-32-3ChemIDplus
Citations